AI Meets Life Sciences & Health: Innovation, IP & Business Value
From breakthrough science to products, protection and commercial impact
AI is reshaping drug discovery, diagnostics, medical devices and digital health. What does it take to turn that potential into successful products and lasting business value?
Join Bereisheet Tech Boston for an evening connecting life sciences, healthcare, AI and intellectual property. Bringing together industry experience and IP perspectives, we’ll explore how companies move from discovery to development, protect what makes their technology valuable, and prepare for partnerships, fundraising and commercialization.
Inside the conversation
AI in practiceHow life sciences and healthcare companies are integrating AI into R&D and product development, with lessons from bringing digital health and medical technologies to market.
Protecting innovationWhere patents and trade secrets fit, the questions AI raises for intellectual property, and how protection strategies can support business growth.
From technology to commercial valueHow product development and IP decisions influence competitive advantage, investor conversations and strategic partnerships.
Featured speaker
Amir ZurExecutive Director, Regional Head of R&D Engineering, Digital UnitOlympus Corporation of the Americas
A Boston community member with more than 20 years of experience across pharma, medical technology and startups, Amir brings expertise in digital health, AI and product commercialization. His background includes leadership roles at Olympus, Takeda and Teva, spanning medical devices, connected therapies and digital health products.
Additional speakers to be announced.
Connect with the community
The evening includes Q&A and networking with founders, executives, researchers, R&D and product leaders, investors and IP professionals working across life sciences, healthcare and AI.
Register to join the conversation and connect with the people building the future of health.